In the study, the only carcinoma of nonlung origin in which Napsin-A was detected was renal cell carcinoma, suggesting that Napsin-A can be used as a surrogate marker in work up of poorly differentiated lung adenocarcinoma or an unknown primary tumor [24]. Here, NAPSA is linked to lung adenocarcinoma.